MSMichael B. Stenger

Michael B. Stenger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael B. Stenger has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cardiovascular Deconditioning and Exercise

    by Michael B. Stenger, Steven S. Laurie, Stuart M. C. Lee, Steven H. Platts


  • Cardiovascular Deconditioning and Exercise

    by Michael B. Stenger, Steven S. Laurie, Stuart M. C. Lee, Steven H. Platts

  • Top Cited Papers
    Open Access

    Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During Spaceflight

    by Karina Marshall-Goebel, Steven S. Laurie, Irina V. Alferova, Philippe Arbeille, Serena M. Auñón-Chancellor, Douglas J. Ebert, Stuart M. C. Lee, Brandon R. Macias, David S. Martin, James M. Pattarini, et al.

    A gravity-induced head-to-foot (Gz) hydrostatic pressure gradient exists in the fluid-filled systems of the body in the upright position on Earth. In the supine position, the gravity vector no longer pulls in the Gz axis; therefore, blood and tissue-fluid pressures and volumes redistribute across the body. By spending approximately two-thirds of the day upright and the remaining one-third of the day supine at night, humans experience fluid shifts daily. However, crew members on the International Space Station (ISS) are weightless and thus experience a sustained redistribution of fluids toward the head that is not subject to daily diurnal posture-induced change in hydrostatic pressure.1 Headward fluid shifts during prolonged weightlessness result in facial puffiness, decreased leg volume, increased stroke volume, and decreased plasma volume.2-4 This fluid shift may also affect cerebral venous outflow as internal jugular vein (IJV) volume has been showed to be increased during 4.0 to 5.5 months of spaceflight exposure.5


  • Cardiovascular Deconditioning and Exercise

    by Michael B. Stenger, Steven S. Laurie, Stuart M. C. Lee, Steven H. Platts


  • Artificial gravity training reduces bed rest-induced cardiovascular deconditioning

    by Michael B. Stenger, Joyce M. Evans, Charles F. Knapp, Stuart M. C. Lee, Tiffany R. Phillips, Sondra A. Perez, Alan D. Moore, William H. Paloski, Steven H. Platts

    We studied 15 men (8 treatment, 7 control) before and after 21 days of 6º head-down tilt to determine whether daily, 1-h exposures to 1.0 Gz (at the heart) artificial gravity (AG) would prevent bed rest-induced cardiovascular deconditioning. Testing included echocardiographic analysis of cardiac function, plasma volume (PV), aerobic power (VO2pk) and cardiovascular and neuroendocrine responses to 80º head-up tilt (HUT). Data collected during HUT were ECG, stroke volume (SV), blood pressure (BP) and blood for catecholamines and vasoactive hormones. Heart rate (HR), cardiac output (CO), total peripheral resistance, and spectral power of BP and HR were calculated. Bed rest decreased PV, supine and HUT SV, and indices of cardiac function in both groups. Although PV was decreased in control and AG after bed rest, AG attenuated the decrease in orthostatic tolerance [pre- to post-bed rest change; control: −11.8 ± 2.0, AG: −6.0 ± 2.8 min (p = 0.012)] and VO2pk [pre- to post-bed rest change; control: −0.39 ± 0.11, AG: −0.17 ± 0.06 L/min (p = 0.041)]. AG prevented increases in pre-tilt levels of plasma renin activity [pre- to post-bed rest change; control: 1.53 ± 0.23, AG: −0.07 ± 0.34 ng/mL/h (p = 0.001)] and angiotensin II [pre- to post-bed rest change; control: 3.00 ± 1.04, AG: −0.63 ± 0.81 pg/mL (p = 0.009)] and increased HUT aldosterone [post-bed rest; control: 107 ± 30 pg/mL, AG: 229 ± 68 pg/mL (p = 0.045)] and norepinephrine [post-bed rest; control: 453 ± 107, AG: 732 ± 131 pg/mL (p = 0.003)]. We conclude that AG can mitigate some aspects of bed rest-induced cardiovascular deconditioning, including orthostatic intolerance and aerobic power. Mechanisms of improvement were not cardiac-mediated, but likely through improved sympathetic responsiveness to orthostatic stress.


  • Gradient Compression Garments as a Countermeasure to Post-Spaceflight Orthostatic Intolerance

    by Michael B. Stenger, Angela K. Brown, Stuart M. C. Lee, James P. Locke, Steven H. Platts

    Stenger MB, Brown AK, Lee SMC, Locke JP, Platts SH. Gradient compression garments as a countermeasure to post-spaceflight orthostatic intolerance. Aviat Space Environ Med 2010; 81:883–7. Introduction: Post-spaceflight orthostatic intolerance affects ~30% of short-duration and 80% of long-duration crewmembers. While the current NASA antigravity suit is effective during Space Shuttle re-entry, it is not designed to be worn postflight and has several drawbacks. The purpose of this study was to evaluate the use of commercially available, thigh-high, gradient compression garments to prevent post-spaceflight orthostatic intolerance. Methods: Before spaceflight, five male Shuttle astronauts were fitted for compression garments. Postflight stand time, blood pressure, heart rate, stroke volume, cardiac output, and peripheral resistance during 10-min, 80° head-up tilt test within 4 h of landing in these astronauts were retrospectively compared to a group of nine male astronauts not wearing the compression garments. Results: On landing day, three of nine non-countermeasure astronauts developed presyncopal symptoms and could not complete the test, while no countermeasure subjects became presyncopal. Compared to the non-countermeasure subjects, the countermeasure subjects had higher systolic blood pressure (116 ± 3 vs. 134 ± 2 mmHg), stroke volume (42 ± 5 vs. 57 ± 6 ml), and cardiac output (3.1 ± 0.3 vs. 4.6 ± 0.4 L). Heart rate was not different between groups. Conclusions: In this small pilot study, the rate of presyncope in the non-countermeasure group was similar to that reported previously in subjects without a compression garment. In contrast, thigh-high graded compression garments mitigated the symptoms of orthostatic intolerance by improving stroke volume, cardiac output, and systolic blood pressure responses to standing.


    • 1 October 2004
      • Vol. 75  (10) , 850-8

    Centrifuge training increases presyncopal orthostatic tolerance in ambulatory men.

    by Joyce M Evans, Michael B Stenger, Fritz B Moore, Helmut Hinghofer-Szalkay, Andreas Rössler, Abhijit R Patwardhan, David R Brown, Michael G Ziegler, Charles F Knapp

    Exposure to spaceflight or simulations of microgravity reduce human postflight orthostatic tolerance. Exercise training and volume loading can reduce associated losses of plasma volume and muscle strength, but are not successful in maintaining postflight orthostatic tolerance. A preliminary study (16) indicated that short bouts of artificial gravity (AG) training on a centrifuge could increase orthostatic tolerance in healthy, ambulatory volunteers. We tested the same AG protocol for its tolerance effect on 14 men who underwent a 3-wk exposure to Gz acceleration training on NASA-Ames' (Moffet Field, CA) human-powered centrifuge. Subjects trained supine (head near the center of rotation) and in pairs (one subject rode passively while the other provided power to operate the 1.9-m centrifuge). The acceleration profile consisted of 7 min at 1 Gz before alternating between 1 and 2.5 Gz at 2-min intervals for 28 min. Each subject's presyncopal orthostatic tolerance limit (to a combination of 70 degrees head-up tilt and increasing lower body negative pressure) was determined before and after training. There were no significant differences between training groups, but presyncopal orthostatic tolerance time was improved 17 +/- 10% (p < 0.05) for the combined groups. Mechanisms associated with increased tolerance included: increased cardiac output (p < 0.04), stroke volume (p < 0.01) and low-frequency spectral power of arterial pressure (p < 0.006), and decreased arterial pressure (p < 0.05) and vascular resistance (p < 0.04). Artificial gravity training in this group of men appears to increase orthostatic tolerance through a combination of decreased vascular resistance and enhanced cardiac function.